2nd Quarter - Termination Amendment

FABIANI & COMPANY for IPIERIAN, INC.

Firm
Client
Income
$50,000
Expenses
—
Terminated
Jun 30, 2011

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 20, 2011 $50,000 Replaced
2nd Quarter - Termination Amendment (this page) Oct 20, 2011 $50,000 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Secure funding to support drug research and development

LobbyistCovered position, as disclosed
ELIZABETH BARROWS —
MELISSA DUPREE —

Contacted: Natl Institutes of Health (NIH); Defense, Dept of (DOD); SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Secure funding to support drug research and development

LobbyistCovered position, as disclosed
ELIZABETH BARROWS —
MELISSA DUPREE —

Contacted: HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); SENATE; Natl Institutes of Health (NIH)

Veterans VET

Secure funding to support drug research and development

LobbyistCovered position, as disclosed
ELIZABETH BARROWS —
MELISSA DUPREE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Defense, Dept of (DOD); Natl Institutes of Health (NIH)

Medical/Disease Research/Clinical Labs MED

Secure funding to support drug research and development

LobbyistCovered position, as disclosed
ELIZABETH BARROWS —
MELISSA DUPREE —

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Defense, Dept of (DOD); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.